{{Drugbox
| IUPAC_name = (8R,9S,13S,14S,17R)-17-ethenyl-17-hydroxy-13-methyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
| image = Norgesterone.svg

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =

<!--Identifiers-->
| CAS_number = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 65606
| ChemSpiderID = 59047

<!--Chemical data-->
| C=20 | H=28 | O=2
| molecular_weight = 300.43512 g/mol
| smiles = CC12CCC3C(C1CCC2(C=C)O)CCC4=C3CCC(=O)C4
| StdInChI = 1S/C20H28O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h3,16-18,22H,1,4-12H2,2H3/t16-,17-,18+,19+,20+/m1/s1
| StdInChIKey = YPVUHOBTCWJYNQ-SLHNCBLASA-N
| synonyms = Vinilestrenolone; 17α-Vinylestr-5(10)-en-17-ol-3-one
}}

'''Norgesterone''' ([[International Nonproprietary Name|INN]]), also known as '''norvinodrel''', '''vinylestrenolone''', or '''vinylnoretynodrel''',<ref name="LaverySanfilippo2012">{{cite book|author1=J.P. Lavery|author2=J.S. Sanfilippo|title=Pediatric and Adolescent Obstetrics and Gynecology|url=https://books.google.com/books?id=l9XTBwAAQBAJ&pg=PA236|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-1-4612-5064-7|pages=236–}}</ref> as well as '''17α-vinylestr-5(10)-en-17β-ol-3-one''' and '''17α-vinyl-δ<sup>5(10)</sup>-19-nortestosterone''', is a [[steroid]]al [[progestin]] of the [[19-nortestosterone]] group that was first described in 1965.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA887|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=887–}}</ref> Combined with [[ethinylestradiol]] as '''Vestalin''', it is (or has been) used as a [[hormonal contraceptive]].<ref name="pmid12254511">{{vcite2 journal | vauthors = Wassef SA, Sami G, Hamid EA | title = Effect of switching with oral contraceptives | journal = Egypt Popul Fam Plann Rev | volume = 3 | issue = 1 | pages = 77–93 | year = 1970 | pmid = 12254511 | doi = | url = }}</ref><ref name="BengtssonTausk1972">{{cite book|author1=Lars Philip Bengtsson|author2=M. Tausk|title=Pharmacology of the endocrine system and related drugs: progesterone, progestational drugs and antifertility agents|url=https://books.google.com/books?id=Nv5sAAAAMAAJ|date=September 1972|publisher=Pergamon Press}}</ref><ref name="Challener2001">{{cite book|author=Cynthia A. Challener|title=Chiral Drugs|url=https://books.google.com/books?id=hyhtAAAAMAAJ|date=1 December 2001|publisher=Wiley|isbn=978-0-566-08411-9}}</ref> Norgesterone is virtually devoid of [[androgen]]ic activity in [[animal research|animal]] [[bioassay|assay]]s.<ref name="RuggieriMatscher1965">{{cite journal|last1=Ruggieri|first1=Pietro de|last2=Matscher|first2=Rodolfo|last3=Lupo|first3=Corrado|last4=Spazzoli|first4=Giacomo|title=Biological properties of 17α-vinyl-5(10)-estrene-17β-ol-3-one (norvinodrel) as a progestational and claudogenic compound|journal=Steroids|volume=5|issue=1|year=1965|pages=73–91|issn=0039-128X|doi=10.1016/0039-128X(65)90133-9}}</ref>

==See also==
* [[Norvinisterone]]
* [[Vinyltestosterone]]
* [[Noretynodrel]]
* [[Normethandrone]]

==References==
{{reflist|30em}}

{{Progestogens and antiprogestogens}}
{{Progesterone receptor modulators}}

[[Category:Estranes]]
[[Category:Progestogens]]
[[Category:Vinyl compounds]]


{{steroid-stub}}